Who owns Dyne Therapeutics Inc (DYN)? Superinvestor holders
2 superinvestors of the 157 tracked here hold Dyne Therapeutics Inc (DYN) in their latest 13F filing, with $24.4M between them. Louis Bacon gives it the most weight: 0.18% of the reported portfolio. In their latest reported quarter, Louis Bacon added.
Key facts
- Superinvestors holding it
- 2 of 157
- Biggest holder
- Julian and Felix Baker, $18.1M
- Largest weight
- Louis Bacon, 0.18%of their portfolio
- Combined value
- $24.4M
- Bought last quarter
- 1
- Sold last quarter
- 0
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Louis BaconMoore Capital Management | 0.18% | $6.3M | 390.74K | ▲ Added 28% | +84.95K | Q3 2026 |
| 2 | Julian and Felix BakerBaker Bros. Advisors | 0.09% | $18.1M | 813.45K | No change | 0 | Q2 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 1 | 390.74K | $6.3M | 1 | 0 |
| Q2 2026 | 157 | 1 | 813.45K | $18.1M | 0 | 0 |
| Q1 2026 | 157 | 2 | 823.45K | $14.9M | 0 | 0 |
| Q4 2025 | 157 | 2 | 823.45K | $16.1M | 1 | 0 |
| Q3 2025 | 157 | 1 | 10K | $126.5K | 0 | 1 |
| Q2 2025 | 157 | 2 | 9.72M | $92.6M | 0 | 1 |
| Q1 2025 | 156 | 3 | 10.4M | $108.7M | 1 | 2 |
| Q4 2024 | 156 | 3 | 7.28M | $171.6M | 0 | 2 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Louis Bacon | 390.74K | — | — | — | — | — | — | — |
| Julian and Felix Baker | · | 813.45K | 813.45K | 813.45K | — | — | 672.1K | 672.1K |
| Andrew Spokes | — | — | 10K | 10K | 10K | 10K | 10K | 229.12K |
| Peter Kolchinsky | · | — | — | — | — | 9.71M | 9.71M | 6.38M |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own DYN?
In their latest 13F filings: Louis Bacon (0.18% of the portfolio, $6.3M), Julian and Felix Baker (0.09% of the portfolio, $18.1M).
Who bought DYN last quarter?
Louis Bacon (added 28%). “Last quarter” is each investor's latest reported quarter.
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Dyne Therapeutics Inc (DYN)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/DYN/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to DYN by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.